Company profile

Ticker
TEVA
Exchange
CEO
Kåre Schultz
Employees
Incorporated in
Location
Fiscal year end
Former names
Teva Pharmaceutical Industries Limited
SEC CIK

TEVA stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

21 Feb 20
25 Feb 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 4.47B 4.09B 4.18B 4.15B
Net income 110M -314M -689M -105M
Diluted EPS 0.1 -0.29 -0.63 -0.1
Net profit margin 2.46% -7.67% -16.50% -2.53%
Operating income 148M -81M -644M 134M
Net change in cash 734M -924M 192M 191M
Cash on hand 1.98B 1.24B 2.17B 1.97B
Cost of revenue 2.03B 2.44B 2.44B 2.44B
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 16.89B 18.27B 22.39B 21.9B
Net income -999M -2.15B -16.27B 329M
Diluted EPS -0.91 -2.35 -16.26 0.07
Net profit margin -5.92% -11.77% -72.66% 1.50%
Operating income -443M -1.64B -17.48B 2.15B
Net change in cash 193M 819M -25M -5.96B
Cash on hand 1.98B 1.78B 963M 988M
Cost of revenue 9.35B 9.98B 11.24B 10.04B

Financial data from company earnings reports

13F holders
Current Prev Q Change
Total holders 0 0 NaN%
Opened positions 0 0 NaN%
Closed positions 0 0 NaN%
Increased positions 0 0 NaN%
Reduced positions 0 0 NaN%
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg

Patents

GRANT
Utility
Compliance monitoring module for a breath-actuated inhaler
25 Feb 20
A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.
APP
Utility
Drug Repurposing Hypothesis Generation Using Clinical Drug-Drug Interaction Information
9 Jan 20
Embodiments of the present systems and methods may provide techniques for systematic drug repositioning that fully leverages drug-drug interactions.
APP
Utility
Automatic Generation of User and Non-User Cohorts for The Estimation of Drug's Effect from Longitudinal Observational Data
2 Jan 20
Embodiments of the present systems and methods may provide generation of user and non-user cohorts for the estimation of drug's effect from longitudinal observational data that provide reduction of biases, account for progression of disease over time, and improve statistical significance.
APP
Utility
Use of Rasagiline for the Treatment of Restless Legs Syndrome
5 Dec 19
Disclosed are methods for the treatment of Restless Legs Syndrome comprising administering an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof.